Royalty Pharma Plc
(NASDAQ) RPRX
Royalty Pharma Plc Financials at a Glance
Market Cap
$19.43B
Revenue (TTM)
$2.38B
Net Income (TTM)
$770.95M
EPS (TTM)
$1.78
P/E Ratio
25.47
Dividend
$0.90
Beta (Volatility)
0.47 (Low)
Dividend
$0.90
Beta (Volatility)
0.47 (Low)
Price
$45.35
Volume
132,609
Open
$45.78
Price
$45.35
Volume
132,609
Open
$45.78
Previous Close
$45.35
Daily Range
$44.74 - $45.84
52-Week Range
$29.66 - $47.86
Dividend
$0.90
Beta (Volatility)
0.47 (Low)
Price
$45.35
Volume
132,609
Open
$45.78
Previous Close
$45.35
Daily Range
$44.74 - $45.84
52-Week Range
$29.66 - $47.86
RPRX News
RPRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Royalty Pharma Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
100
CEO
Pablo Gerardo Legorreta
Website
royaltypharma.comHeadquarters
New York City, NY 10022, US
RPRX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
66%
Net Income Margin
32%
Return on Equity
11%
Return on Capital
8%
Return on Assets
4%
Earnings Yield
3.93%
Dividend Yield
0.02%
Payout Ratio
49.06%
Stock Overview
Market Cap
$19.43B
Shares Outstanding
428.42M
Volume
132.61K
Short Interest
0.00%
Avg. Volume
3.58M
Financials (TTM)
Gross Profit
$2.38B
Operating Income
$1.56B
EBITDA
$1.64B
Operating Cash Flow
$2.49B
Capital Expenditure
$0.00
Free Cash Flow
$2.49B
Cash & ST Invst.
$637.50M
Total Debt
$8.95B
Royalty Pharma Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$621.99M
+4.8%
Gross Profit
$621.99M
+4.8%
Gross Margin
100.00%
N/A
Market Cap
$19.43B
N/A
Market Cap/Employee
$259.11M
N/A
Employees
75
N/A
Net Income
$214.21M
+2.9%
EBITDA
$451.28M
+12.8%
Quarterly Fundamentals
Net Cash
$8.31B
-42.3%
Accounts Receivable
$883.70M
+3178.3%
Inventory
$0.00
N/A
Long Term Debt
$8.59B
+29.8%
Short Term Debt
$380.00M
-61.9%
Return on Assets
3.93%
N/A
Return on Invested Capital
8.21%
N/A
Free Cash Flow
$827.15M
+11.4%
Operating Cash Flow
$827.15M
+11.4%